- Home
- / Array BioPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Array BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$173.8 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 85.1M | 69.6M | 42.1M | 51.9M | 137.9M | 150.9M | 173.8M |
| Revenue growth, % | 23.4% | 165.6% | |||||
| Cost of goods sold | 24.3M | 30.1M | 46.0M | 44.4M | 23.2M | 35.4M | 59.4M |
| Gross profit | 60.9M | 39.5M | (3.9M) | 7.5M | 114.7M | 115.5M | 114.4M |
| Gross profit margin, % | 71.5% | 56.8% | -9.2% | 14.5% | 83.2% | 76.5% | 65.8% |
| General and administrative expense | 15.2M | 19.6M | 21.9M | 31.4M | 36.3M | 39.3M | 58.5M |
| Operating expense total | 71.9M | 79.0M | 71.7M | 4.2M | 196.9M | 217.5M | 244.3M |
| EBIT | (11.0M) | (39.5M) | (75.6M) | 3.3M | (82.2M) | (102.1M) | (129.9M) |
| EBIT margin, % | -13.0% | -56.8% | -179.7% | 6.3% | -59.6% | -67.7% | -74.8% |
| Interest income | 32.0K | 55.0K | 77.0K | 68.0K | 243.0K | 796.0K | 4.5M |
| Interest expense | 11.6M | 11.3M | 6.1M | 10.6M | 14.7M | 15.1M | |
| Pre tax profit | (23.6M) | ||||||
| Income tax expense | 2.3M | ||||||
| Net Income | (23.6M) | (61.9M) | (85.3M) | 9.4M | (92.8M) | (116.8M) | (147.7M) |